Cre/loxP-Mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7533-7540

  Fernex, Corinne ^a   Dubreuil, Patrice ^b   Mannoni, Patrice ^a   Bagnis, Claude ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NEOMYCIN; VIRUS VECTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL DIFFERENTIATION; DNA FLANKING REGION; EXCISION REPAIR; GENETIC RECOMBINATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROMOTER REGION; RETROVIRUS; SIGNAL TRANSDUCTION; VIRUS TRANSCRIPTION;

EID: 0030800730     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7533-7540.1997     Document Type: Article

References (37)

1. Apperley, J. F., B. D. Luskey, and D. A. Williams. 1991. Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: effect of selectable marker sequences on long-term expression. Blood 78:310-317.
2. Artelt, P., R. Grannemann, C. Stocking, J. Friel, J. Bartsch, and H. Hauser. 1991. The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene 99:249-254.
3. Bagnis, C., C. Chisehportich, A. M. Imbert, A. Van Den Broeke, V. Cornet, and P. Mannoni. 1997. Efficiency of retroviral transduction into hematopoietic cells by cocultivation does not correlate with viral titer. Cancer Gene Ther. 4:5-8.
4. Bergemann, B., K. Kühlcke, B. Fehse, I. Ratz, W. Ostertag, and H. Lother. 1996. Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination. Nucleic Acids Res. 23:4451-4456.
5. Bestor, T. H., and G. L. Verdine. 1994. DNA methyltransferases. Curr. Opin. Cell Biol. 6:380-389.
6. Bird, A. P. 1993. Functions for DNA methylation in vertebrates. Cold Spring Harbor Symp. Quant. Biol. 58:281-285.
7. Bowtell, D. L., S. Cory, D. R. Johnson, and T. J. Gonda. 1988. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J. Virol. 62:2464-2473,
8. Choulika, A., V. Guyot, and J. F. Nicolas. 1996. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. J. Virol. 70:1792-1798.
9. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hnmada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539-3543.
10. Emerman, M., and H. M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigcnetic mechanism. Cell 39:459-467.
11. Emerman, M., and H. M. Temin. 1986. Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol. Cell. Biol. 6:792-800.
12. Fernex, C. Unpublished data.
13. Groopman, J. E., J.-M. Molina, and D. T. Scadden. 1989. Hematopoietic growth factors. Biology and clinical applications. N. Engl. J. Med. 321:1449-1459.
14. Imbert, A. M., R. Costello, J. Imbert, P. Mannuni, and C. Bagnis. 1994. Highly efficient retroviral gene transfer into human primary T-lymphocytes derived from the peripheral blood. Cancer Gene Ther. 1:259-265.
15. Kane, S. E., I. Pastan, and M. M. Gottesman. 1989. A new vector using the human muitidrug resistance gene as a selectable marker enables overexpression of foreign genes in eukaryotic cells. Gene 84:439-446.
16. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97-104.
17. Karlsson, S. 1991. Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78:2481-2492.
18. Kilby, N. J., M. R. Snaith, and J. A. H. Murray. 1993, Site-specific recombinases: tools for genome engineering. Trends Genet. 9:413-421.
19. Kruys, V., O. Marinx, G. Shaw, J. Deschamps, and G. Huez. 1989. Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245:852-855.
20. Lozzio, B. B., and C. B. Lozzio. 1979. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leukemia Res. 3: 363-370.
21. Lund, A. H., M. Duch, and F. S. Pedersen. 1996. Transcriptional silencing of retroviral vectors. J. Biomed. Sci. 3:365-378.
22. Lynch, C. M., and A. D. Miller. 1991. Production of high-liter helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J. Virol. 65:3887-3890.
23. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient packaging cell line. Virology 167:400-406.
24. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
25. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
26. Olsen, J. C., L. G. Johnson, M. L. Wong-Sun, K. L. Moore, R. Swanstrom, and R. C. Boucher. 1993. Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: effect of selectable marker sequences on long-term expression. Nucleic Acids Res. 21:663-669.
27. Park, L., P. E. Waldron, D. Friend, H. M. Sassenfeld, V. Price, D. Anderson, D. Cosman, R. A. Andrews, I. D. Bernstein, and D. L. Urdal. 1989. Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood 74:55-65.
28. Pawliuk, R., R. Kay, P. Lansdorp, and R. K. Humphries. 1994. Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84:2868-2877.
29. Rohlmann, A., M. Gotthardt, T. E. Willnow, R. E. Hammer, and J. Herz. 1996. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat. Biotech. 14:1562-1565.
30. Russ, A. P., C. Friedel, M. Grez, and H. von Melchner. 1996. Self-deleting retrovirus for gene therapy. J. Virol. 70:4927-4932.
31. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
32. Sauer, B., and N. Henderson. 1992. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 2:441-449.
33. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
34. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
35. Sternberg, N., and D. Hamilton. 1981. Bacteriophage P1 site-specific recombination. 1. Recombination between loxP sites. J. Mol. Biol. 150:467-486.
36. Stuhlmann, H., R. Jaenisch, and R. C. Mulligan. 1989. Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol. Cell. Biol. 9:100-108.
37. Wang, Y., L. A. Knishel, and G. M. Edelman. 1996. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase. Proc. Natl. Acad. Sci. USA 93:3932-3936.